Scope in OTC Cough, Cold & Allergy Medicines Market: Size | Trends | Key Players |and Forecast till 2022

Fact.MR Fact.MR

Rockville, US, 2018-Mar-14 — /EPR Network/ — A fresh study, covering “OTC Cough, Cold & Allergy Medicine Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the OTC Cough, Cold & Allergy Medicine market.

Request for Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=71

Factors as such are playing a crucial role in further boosting the demand for OTC cough, cold and allergy medicines. In addition, growing number of immunosuppressed patients and expanding global geriatric population is anticipated to drive the growth of the market. Fact.MR’s recently published report reveals that the global cough, cold and allergy medicine market is set to witness 4.9% between 2017 and 2022. This market is estimated to stand at around US$ 37,323 Mn towards the end of the forecast period.

Following insights from Fact.MR’s global OTC cough, cold and allergy market will be important for market’s future growth

1- The OTC cough, cold and allergy medicines market in Asia Pacific excluding Japan (APEJ) is anticipated to remain highly attractive throughout the assessment period. In 2017 and beyond, the region is projected to command for a noteworthy revenue share of the global market. This is primarily owing to dropping air quality and increase pollution that is resulting in higher occurrence of respiratory ailments.  In addition, rapid adoption of OTC medicines owing to their convenience of purchase and cost-efficiency is facilitating the growth of the market in the region.

2- On the basis of drug type, antihistamine is anticipated to command for over one-third revenues share of the market by the end of 2017.  Antihistamines drugs help in restricting the histamine release from histamine-1 receptors, moreover these drugs can effectively treat watery eyes or runny nose, inflammation (redness), sneezing and swelling (edema).

3- By OCT channel, pharmacies will continue to be the top OCT channel for sales of allergy, cold and cough drugs between 2017 and 2022. During the same time, the drug store segment is projected to retain its second spot.

4- Based on dosage, the tablet segment is projected to command for a significant share of the market in terms of revenue and is likely to reach a valuation of nearly US$ 12,425 Mn over 2022.

Competition Tracking

Fact.MR has profiled some of the key players in its report, which include Allergen, Bristol-Myers Squib Co., Prestige Brands Holdings, Inc., Pfizer Inc., GlaxoSmithKline Plc., Reckitt Benckiser Group Plc., AstraZaneca Plc., Johnson & Johnson Service, Inc., Procter & Gamble Co., Sanofi-Aventis, Novartis AG, Merck & Co., and Sun Pharmaceutical Industries Ltd. Many of these companies are concentrating on improving the product efficiency in order to increase their market presence.

Browse Full Report with TOC – https://www.factmr.com/report/71/otc-cough-cold-allergy-medicine-market                                                                                                                                                                    

Table of Contents:

  1. Global OTC Cough, Cold and Allergy Medicines Market – Executive Summary
  2. Global OTC Cough, Cold and Allergy Medicines Market Overview
    2.1. Introduction
    2.1.1. Global OTC Cough, Cold and Allergy Medicines Market Taxonomy
    2.1.2. Global OTC Cough, Cold and Allergy Medicines Market Definition
    2.2. Global OTC Cough, Cold and Allergy Medicines Market Size (US$ Mn) and Forecast, 2012-2022
    2.2.1. Global OTC Cough, Cold and Allergy Medicines Market Y-o-Y Growth
    2.3. Global OTC Cough, Cold and Allergy Medicines Market Dynamics
    2.3.1. Drivers
    2.3.2. Restraints
    2.3.3. Trends
    2.4. Supply Chain
    2.5. Epidemiology
    2.6. List of Distributors
    2.7. Average Pricing Analysis
    2.8. Regulations
    2.9. Key Participants Market Presence (Intensity Map) By Region
  3. Global OTC Cough, Cold and Allergy Medicines Market Analysis and Forecast By Drug Type
    3.1. Global OTC Cough, Cold and Allergy Medicines Market Size and Forecast By Drug Type, 2012-2022
    3.1.1. Antihistamine OTC Cough, Cold and Allergy Medicines Market Size and Forecast, 2012-2022
    3.1.1.1. Revenue (US$ Mn) Comparison, By Region
    3.1.1.2. Market Share Comparison, By Region
    3.1.1.3. Y-o-Y growth Comparison, By Region
    3.1.2. Expectorants OTC Cough, Cold and Allergy Medicines Market Size and Forecast, 2012-2022
    3.1.2.1. Revenue (US$ Mn) Comparison, By Region
    3.1.2.2. Market Share Comparison, By Region
    3.1.2.3. Y-o-Y growth Comparison, By Region
    3.1.3. Bronchodialators OTC Cough, Cold and Allergy Medicines Market Size and Forecast, 2012-2022
    3.1.3.1. Revenue (US$ Mn) Comparison, By Region
    3.1.3.2. Market Share Comparison, By Region
    3.1.3.3. Y-o-Y growth Comparison, By Region

Continued…….

Check Discount on this Report – https://www.factmr.com/connectus/sample?flag=D&rep_id=71        

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

Matched content

Editor’s pick